HS

Hitesh Savjibhai Kalathiya

Active Director Designated Partner DIN 09047728
DIN 09047728 First appointment Feb 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitesh Savjibhai Kalathiya

Data last updated:

Hitesh Savjibhai Kalathiya is a Designated Partner at Benzmark Pharmachem Llp (since 2021). The company operates in Chemicals.

DIN 09047728
Primary Designation Designated Partner
Industry Chemicals
First Appointment 01 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Feb 20212021Active

Board colleagues of Hitesh Savjibhai Kalathiya

NameDINCompanyDesignation
Jigneshkumar Mansukhbhai Sorathiya08793945Benzmark Pharmachem LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Benzmark Pharmachem Llp
Premium access

Shareholding and investment profile for Hitesh Savjibhai Kalathiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Savjibhai Kalathiya

Hitesh Savjibhai Kalathiya currently holds 1 directorship: Benzmark Pharmachem Llp (Designated Partner, since 01 Feb 2021).

Hitesh Savjibhai Kalathiya was first appointed on 01 Feb 2021 as Designated Partner at Benzmark Pharmachem Llp.

The current boards of Hitesh Savjibhai Kalathiya's companies include Jigneshkumar Mansukhbhai Sorathiya (Benzmark Pharmachem Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available